Campus alert status is yellow: For the latest campus alert status, news and resources, visit umassmed.edu/coronavirus

Search Close Search
Page Menu

Research Associates

  • Motahareh Arjomandnejad

    Motahareh Arjomandnejad

    Education:

    BSc: Cellular and Molecular Biology, Shahid Chamran University, Ahvaz, Iran
    MS: Biotechnology, Alzahra University, Tehran, Iran 
    PhD: Medical Biotechnology, Tarbiat Modares University, Tehran, Iran (2014-)
    PhD: Immunology, University of Massachusetts Medical School, Worcester, MA (2019-)

    A limiting factor in the widespread application of gene therapy is the induction of an immune response. In systemic Adeno Associated Virus (AAV) gene therapy, there is an immune response to both the AAV vehicle and the introduced transgene. My project focuses on generation of chimeric antigen receptor regulatory T cells (CAR-Tregs) to suppress an immune response against AAV gene therapy and the introduced transgene.

  • Ishani Dasgupta

    Ishani Dasgupta, PhD

    Academic Role: Post-Doctoral Fellow

    Education: PhD - Molecular and Cell Biology, Nanyang Technological University

    MS - Biotechnology, University of Calcutta

    BS - Microbiology, University of Calcutta

    Ishani also serves as the Events Director of Central Mass chapter of AWIS (Association for Women in Science)

  • Acadia Kopec

    Acadia Kopec

    Education: BA - Stonehill College

  • Olivia Sears

    Olivia Sears

    Academic Role: Medical Student

    Education: MD Candidate - Class of 2023, University of Massachusetts Medical School

    BS -Behavioral Neuroscience and Marine Biology - Northeastern University

  • Katelyn Sylvia

    Katelyn Sylvia

    Academic Role: Lab Manager

    Education: BA - Biology, College of the Holy Cross

  • Qiushi Tang

    Qiushi Tang

    Academic Role: Senior Research Scientist

    Education: BS - Chemistry, Jilin University 

                         MS - Biochemistry, Jilin University 

    Working on recombinant adeno-associated virus (AAV) gene therapy vectors for alpha-1-antitrypsin deficiency (AAT). Focusing on dual-function AAV vector to augment wild-type(M-AAT) with simultaneous mutate AAT( Z-AAT) knockdown in a transgenic mouse model. My other focus is on NSG-PiZ  humanized mouse model to provide a platform for future studies of both cell based and genetic therapies of AAT deficiency

  • Baby Yoda

    Baby Yoda

    Academic Role: Lab Mascot

    Interests: Warm soup, frogs, and shiny objects.

    Dislikes: Baby Groot